BridgeBio Pharma (BBIO) Net Margin (QoQ) (2020 - 2026)
BridgeBio Pharma (BBIO) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
BridgeBio Pharma |
13.01 Bn |
12.08 Bn |
184.58 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
4,076.00 |
| Dec 31, 2025 |
2,631.00 |
| Sep 30, 2025 |
1,312.00 |
| Jun 30, 2025 |
-2,098.00 |
| Mar 31, 2025 |
436,257.00 |
| Dec 31, 2024 |
142,507.00 |
| Sep 30, 2024 |
-254,299.00 |
| Jun 30, 2024 |
-337,151.00 |
| Mar 31, 2024 |
961,931.00 |
| Dec 31, 2023 |
-530,944.00 |
| Sep 30, 2023 |
529,557.00 |
| Jun 30, 2023 |
-194,655.00 |
| Mar 31, 2023 |
-31,777.00 |
| Dec 31, 2022 |
3.33 Mn |
| Sep 30, 2022 |
-4.06 Mn |
| Jun 30, 2022 |
1.16 Mn |
| Mar 31, 2022 |
-1.01 Mn |
| Dec 31, 2021 |
518,075.00 |
| Sep 30, 2021 |
-551,901.00 |
| Jun 30, 2021 |
3.42 Mn |
